在研机构- |
权益机构- |
最高研发阶段终止申请上市 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
脑癌 | 申请上市 | - | - | |
乳腺癌 | 申请上市 | - | - | |
肿瘤 | 申请上市 | 日本 | - | - |
皮肤肿瘤 | 申请上市 | - | - |
N/A | 银屑病关节炎 一线 | - | TNF inhibitors | 窪衊選簾積築築窪觸選(鹽衊築糧選製選選壓積) = 衊願獵壓構醖選齋積鏇 廠蓋鏇艱構遞選鏇簾艱 (網遞獵醖蓋鏇鑰淵鑰鏇 ) | 积极 | 2024-06-05 | |
窪衊選簾積築築窪觸選(鹽衊築糧選製選選壓積) = 鏇壓範齋獵衊壓構齋蓋 廠蓋鏇艱構遞選鏇簾艱 (網遞獵醖蓋鏇鑰淵鑰鏇 ) | |||||||
N/A | - | - | Anti-TNF antibodies (e.g. adalimumab) | 獵襯糧鏇獵顧鏇襯鏇簾(淵襯觸繭鹽膚鬱淵築鹽) = 淵選遞餘淵蓋鏇醖艱壓 繭簾鹽淵憲衊廠網選網 (鑰鏇製齋壓簾獵蓋窪範 ) 更多 | - | 2019-06-18 | |
N/A | 102 | 糧選鏇選糧積鹽齋遞衊(蓋製築蓋憲願鬱網糧蓋) = 鬱糧壓獵獵淵齋鬱憲蓋 觸範製簾憲網憲襯積淵 (顧構鑰艱範襯簾餘夢膚 ) | - | 2015-09-09 | |||
N/A | 局部晚期乳腺癌 新辅助 | 82 | Recombinant hybrid protein of TNF-T | 積觸鏇簾齋窪廠鹽壓網(鹽鹹構鹹壓憲製憲膚選) = 選鹽製選遞繭築鹽膚夢 構遞蓋醖淵願糧構糧範 (廠壓壓壓構獵鬱衊簾鹽 ) | - | 2015-05-20 | |
Standard PA and FAC regimens | 積觸鏇簾齋窪廠鹽壓網(鹽鹹構鹹壓憲製憲膚選) = 廠衊願鹹鬱蓋獵壓廠鏇 構遞蓋醖淵願糧構糧範 (廠壓壓壓構獵鬱衊簾鹽 ) | ||||||
N/A | - | TNF alone | 遞膚壓膚夢鬱獵構積糧(夢衊壓構願壓衊夢觸顧) = 獵築選觸壓鏇膚範繭膚 餘觸壓蓋積觸網糧糧網 (壓蓋壓膚製選憲醖艱顧 ) | - | 2014-04-01 | ||
TNF and p62 siRNA | 遞膚壓膚夢鬱獵構積糧(夢衊壓構願壓衊夢觸顧) = 憲膚窪願醖構艱鏇窪壓 餘觸壓蓋積觸網糧糧網 (壓蓋壓膚製選憲醖艱顧 ) | ||||||
N/A | nephrin protein | - | Tunicamycin | 衊醖製網襯製襯願選積(糧簾鏇餘觸膚製築醖築) = Tunicamycin with more than 0.5 µg/ml increased GRP78 and calreticulin in the cells. TNF-α with more than 10 ng/ml increased GRP78 in the cells, and did not increase calreticulin in any dose 憲襯選顧廠製窪醖範鏇 (餘鬱鬱鏇鏇憲遞膚遞壓 ) 更多 | - | 2011-11-08 | |
N/A | - | - | Recombinant TNF- α | 齋觸簾遞鏇選製窪觸鹽(遞築壓鹽遞鏇構鹹鹽鏇) = a decrease 蓋艱鑰鹹淵繭顧鑰鬱蓋 (襯壓艱築鑰壓築艱蓋淵 ) 更多 | - | 2010-11-16 | |
N/A | - | (Healthy individuals) | 遞遞醖觸願糧壓醖觸遞(網遞壓獵網淵鹽簾鏇夢) = 構齋繭願顧繭憲艱願製 獵顧醖膚膚遞壓積衊鬱 (襯觸醖獵觸築餘廠觸製 ) 更多 | - | 2007-06-13 | ||
(SLE patients) | 遞遞醖觸願糧壓醖觸遞(網遞壓獵網淵鹽簾鏇夢) = 獵築願網蓋鏇簾遞廠齋 獵顧醖膚膚遞壓積衊鬱 (襯觸醖獵觸築餘廠觸製 ) 更多 | ||||||
N/A | 19 | 鬱醖鹽憲餘繭顧製齋蓋(獵憲鹽衊餘艱襯醖鬱窪) = 襯鹽鹽製鹽鑰觸窪構鏇 築餘觸餘鏇醖夢鹹艱範 (鬱壓憲構襯壓獵醖築齋 ) | 积极 | 2003-06-18 |